81
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Clinical outcomes after initial treatment of methicillin-resistant Staphylococcus aureus infections

, , , , , , , & show all
Pages 1073-1081 | Published online: 06 Aug 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yunchao Wang, Ning Dai, Wei Wei & Chunyan Jiang. (2021) Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older. Clinical Interventions in Aging 16, pages 1023-1035.
Read now
Giovanni Di Perri, Andrea Calcagno, Alice Trentalange & Stefano Bonora. (2019) The clinical pharmacology of integrase inhibitors. Expert Review of Clinical Pharmacology 12:1, pages 31-44.
Read now

Articles from other publishers (8)

Koji Toma, Yui Satomura, Kenta Iitani, Takahiro Arakawa & Kohji Mitsubayashi. (2023) Long-range surface plasmon aptasensor for label-free monitoring of vancomycin. Biosensors and Bioelectronics 222, pages 114959.
Crossref
Luo Yi-Fan, Wang Yi-Dan, Ren Li-Xiang & Chu Yang. (2023) A retrospective analysis to estimate trough concentrations of teicoplanin in patients with suspected or documented Gram-positive infections. Brazilian Journal of Pharmaceutical Sciences 59.
Crossref
Kazuaki Matsumoto, Kazutaka Oda, Kensuke Shoji, Yuki Hanai, Yoshiko Takahashi, Satoshi Fujii, Yukihiro Hamada, Toshimi Kimura, Toshihiko Mayumi, Takashi Ueda, Kazuhiko Nakajima & Yoshio Takesue. (2022) Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Pharmaceutics 14:3, pages 489.
Crossref
Toshinori Hirai, Keiko Hosohata, Yukari Ogawa & Takuya Iwamoto. (2021) Clinical predictors of nephrotoxicity associated with teicoplanin: Meta‐analysis and meta‐regression. Basic & Clinical Pharmacology & Toxicology 130:1, pages 110-121.
Crossref
Sean N Avedissian, Marc H Scheetz & Nicolás Cortés-Penfield. (2021) Early Switch From Vancomycin to Daptomycin in Methicillin-Resistant Staphylococcus aureus Bacteremia: Still More Questions Than Answers . Clinical Infectious Diseases 73:6, pages 1128-1129.
Crossref
Moeko Tsutsuura, Hiromu Moriyama, Nana Kojima, Yuki Mizukami, Sho Tashiro, Sumika Osa, Yuki Enoki, Kazuaki Taguchi, Kazutaka Oda, Satoshi Fujii, Yoshiko Takahashi, Yukihiro Hamada, Toshimi Kimura, Yoshio Takesue & Kazuaki Matsumoto. (2021) The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing. BMC Infectious Diseases 21:1.
Crossref
Marin L Schweizer, Kelly Richardson, Mary S Vaughan Sarrazin, Michihiko Goto, Daniel J Livorsi, Rajeshwari Nair, Bruce Alexander, Brice F Beck, Michael P Jones, Mireia Puig-Asensio, Daniel Suh, Madeline Ohl & Eli N Perencevich. (2021) Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections . Clinical Infectious Diseases 72:Supplement_1, pages S68-S73.
Crossref
Dominique J. PepperJunfeng SunXizhong CuiJudith WelshCharles NatansonPeter Q. Eichacker. (2019) Antibiotic- and Fluid-Focused Bundles Potentially Improve Sepsis Management, but High-Quality Evidence Is Lacking for the Specificity Required in the Centers for Medicare and Medicaid Service’s Sepsis Bundle (SEP-1)*. Critical Care Medicine 47:10, pages 1290-1300.
Crossref